Moneycontrol PRO

business

Ranbaxy's revival tough; 5-10% correction likely: Antique

In an interview to CNBC-TV18, Ganjoo says despite the company's legal saga in the US coming to an end, the company will find it difficult to see a full blown recovery.

first published: May 24, 2013 12:11 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347